ICYMI: Cell and Gene Therapy in Medicaid We are living at the leading edge of cell and gene therapies (CGT) rapidly proliferating in the health care system including some one-time, durable treatments for rare and severe genetic conditions like cancers and sickle cell disease (SCD)
1b-c) in presence and absence of blood as biological matrix
In addition to benefits in liver histology, resmetirom also had favorable effects on plasma lipid profile, with significant reductions in atherogenic lipids, including plasma LDL cholesterol, apolipoprotein B, triglycerides, and lipoprotein(a) levels (Harrison et al., 2024[29]
1 Andy Morling, head of the MHRAs Criminal Enforcement Unit, called it a landmark result and a major blow to the illegal trade
The GLP-1 and breast cancer guide covers the current evidence on the relationship between GLP-1 agonists and breast cancer risk, which is an area of active research